Table 3 Symptoms scores on the last day of the treatment week (Day 5) and the last day of the maintenance period (2-month follow-up).
Treatment week + Maintenance period | ||||
|---|---|---|---|---|
Symptom scores (Mean ± SD) | tACS + tACS (n = 8) | tACS + Sham (n = 6) | Sham + tACS (n = 5) | Sham + Sham (n = 6) |
Day 5 | ||||
AHRS | 25.1 ± 8.0 | 19.8 ± 5.1 | 25.6 ± 6.8 | 21.0 ± 5.9 |
HPSVQ | 25.9 ± 8.4 | 23.2 ± 5.3 | 26.4 ± 5.7 | 23.2 ± 1.8 |
PANSS | ||||
–Total | 66.1 ± 14.7 | 58.2 ± 14.6 | 67.8 ± 5.0 | 64.7 ± 17.9 |
–Positive symptoms | 18.6 ± 4.0 | 17.2 ± 4.7 | 16.6 ± 3.4 | 17.3 ± 5.2 |
–Negative symptoms | 15.5 ± 5.1 | 15.0 ± 7.0 | 17.6 ± 6.5 | 17.7 ± 3.5 |
–General psychopathology | 32.0 ± 8.4 | 26.0 ± 5.7 | 22.6 ± 2.4 | 29.7 ± 10.3 |
–Hallucinations | 4.4 ± 0.7 | 4.8 ± 0.8 | 4.6 ± 0.5 | 4.7 ± 1.0 |
2-month follow-up | ||||
AHRS | 23.9 ± 9.6 | 15.7 ± 5.0 | 26.4 ± 6.8 | 17.6 ± 7.1 |
HPSVQ | 25.6 ± 9.8 | 20.5 ± 5.7 | 26.5 ± 4.2 | 20.3 ± 4.6 |
PANSS | ||||
–Total | 67.0 ± 10.1 | 58.0 ± 12.6 | 65.2 ± 5.2 | 60.0 ± 20.4 |
–Positive symptoms | 18.3 ± 3.9 | 17.0 ± 3.2 | 17.2 ± 2.17 | 15.7 ± 5.2 |
–Negative symptoms | 16.3 ± 5.3 | 15.7 ± 6.8 | 16.8 ± 4.4 | 15.5 ± 5.0 |
–General psychopathology | 32.5 ± 5.8 | 25.3 ± 5.4 | 31.2 ± 2.5 | 28.8 ± 11.0 |
–Hallucinations | 4.4 ± 0.7 | 4.3 ± 0.8 | 4.6 ± 0.5 | 4.5 ± 0.8 |
